BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 25046107)

  • 1. Inhibition of autophagy attenuates pancreatic cancer growth independent of TP53/TRP53 status.
    Yang A; Kimmelman AC
    Autophagy; 2014 Sep; 10(9):1683-4. PubMed ID: 25046107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53 status determines the role of autophagy in pancreatic tumour development.
    Rosenfeldt MT; O'Prey J; Morton JP; Nixon C; MacKay G; Mrowinska A; Au A; Rai TS; Zheng L; Ridgway R; Adams PD; Anderson KI; Gottlieb E; Sansom OJ; Ryan KM
    Nature; 2013 Dec; 504(7479):296-300. PubMed ID: 24305049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concurrent Inhibition of IGF1R and ERK Increases Pancreatic Cancer Sensitivity to Autophagy Inhibitors.
    Stalnecker CA; Grover KR; Edwards AC; Coleman MF; Yang R; DeLiberty JM; Papke B; Goodwin CM; Pierobon M; Petricoin EF; Gautam P; Wennerberg K; Cox AD; Der CJ; Hursting SD; Bryant KL
    Cancer Res; 2022 Feb; 82(4):586-598. PubMed ID: 34921013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SETDB1 Inhibits p53-Mediated Apoptosis and Is Required for Formation of Pancreatic Ductal Adenocarcinomas in Mice.
    Ogawa S; Fukuda A; Matsumoto Y; Hanyu Y; Sono M; Fukunaga Y; Masuda T; Araki O; Nagao M; Yoshikawa T; Goto N; Hiramatsu Y; Tsuda M; Maruno T; Nakanishi Y; Hussein MS; Tsuruyama T; Takaori K; Uemoto S; Seno H
    Gastroenterology; 2020 Aug; 159(2):682-696.e13. PubMed ID: 32360551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autophagy is critical for pancreatic tumor growth and progression in tumors with p53 alterations.
    Yang A; Rajeshkumar NV; Wang X; Yabuuchi S; Alexander BM; Chu GC; Von Hoff DD; Maitra A; Kimmelman AC
    Cancer Discov; 2014 Aug; 4(8):905-13. PubMed ID: 24875860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autophagy Blockage Reduces the Incidence of Pancreatic Ductal Adenocarcinoma in the Context of Mutant
    Mainz L; Sarhan MAFE; Roth S; Sauer U; Maurus K; Hartmann EM; Seibert HD; Rosenwald A; Diefenbacher ME; Rosenfeldt MT
    Front Cell Dev Biol; 2022; 10():785252. PubMed ID: 35372352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. UBL4A inhibits autophagy-mediated proliferation and metastasis of pancreatic ductal adenocarcinoma via targeting LAMP1.
    Chen H; Li L; Hu J; Zhao Z; Ji L; Cheng C; Zhang G; Zhang T; Li Y; Chen H; Pan S; Sun B
    J Exp Clin Cancer Res; 2019 Jul; 38(1):297. PubMed ID: 31288830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of chloroquine and hydroxychloroquine on the sensitivity of pancreatic cancer cells to targeted therapies.
    McCubrey JA; Abrams SL; Follo MY; Manzoli L; Ratti S; Martelli AM; Cervello M
    Adv Biol Regul; 2023 Jan; 87():100917. PubMed ID: 36243652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of ratiometrically designed nanocarrier targeting CDK4/6 and autophagy pathways for effective pancreatic cancer treatment.
    Ji Y; Liu X; Li J; Xie X; Huang M; Jiang J; Liao YP; Donahue T; Meng H
    Nat Commun; 2020 Aug; 11(1):4249. PubMed ID: 32843618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of Pancreatic Cancer Patient-Derived Xenograft Panel with Metabolic Inhibitors Reveals Efficacy of Phenformin.
    Rajeshkumar NV; Yabuuchi S; Pai SG; De Oliveira E; Kamphorst JJ; Rabinowitz JD; Tejero H; Al-Shahrour F; Hidalgo M; Maitra A; Dang CV
    Clin Cancer Res; 2017 Sep; 23(18):5639-5647. PubMed ID: 28611197
    [No Abstract]   [Full Text] [Related]  

  • 11. MYC-mediated resistance to trametinib and HCQ in PDAC is overcome by CDK4/6 and lysosomal inhibition.
    Silvis MR; Silva D; Rohweder R; Schuman S; Gudipaty S; Truong A; Yap J; Affolter K; McMahon M; Kinsey C
    J Exp Med; 2023 Mar; 220(3):. PubMed ID: 36719686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. JTC801 Induces pH-dependent Death Specifically in Cancer Cells and Slows Growth of Tumors in Mice.
    Song X; Zhu S; Xie Y; Liu J; Sun L; Zeng D; Wang P; Ma X; Kroemer G; Bartlett DL; Billiar TR; Lotze MT; Zeh HJ; Kang R; Tang D
    Gastroenterology; 2018 Apr; 154(5):1480-1493. PubMed ID: 29248440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lysosome inhibition sensitizes pancreatic cancer to replication stress by aspartate depletion.
    Elliott IA; Dann AM; Xu S; Kim SS; Abt ER; Kim W; Poddar S; Moore A; Zhou L; Williams JL; Capri JR; Ghukasyan R; Matsumura C; Tucker DA; Armstrong WR; Cabebe AE; Wu N; Li L; Le TM; Radu CG; Donahue TR
    Proc Natl Acad Sci U S A; 2019 Apr; 116(14):6842-6847. PubMed ID: 30894490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sirtuin 4 activates autophagy and inhibits tumorigenesis by upregulating the p53 signaling pathway.
    Li J; Zhan H; Ren Y; Feng M; Wang Q; Jiao Q; Wang Y; Liu X; Zhang S; Du L; Wang Y; Wang C
    Cell Death Differ; 2023 Feb; 30(2):313-326. PubMed ID: 36209169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inactivation of Brca2 cooperates with Trp53(R172H) to induce invasive pancreatic ductal adenocarcinomas in mice: a mouse model of familial pancreatic cancer.
    Feldmann G; Karikari C; dal Molin M; Duringer S; Volkmann P; Bartsch DK; Bisht S; Koorstra JB; Brossart P; Maitra A; Fendrich V
    Cancer Biol Ther; 2011 Jun; 11(11):959-68. PubMed ID: 21455033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levels of the Autophagy-Related 5 Protein Affect Progression and Metastasis of Pancreatic Tumors in Mice.
    Görgülü K; Diakopoulos KN; Ai J; Schoeps B; Kabacaoglu D; Karpathaki AF; Ciecielski KJ; Kaya-Aksoy E; Ruess DA; Berninger A; Kowalska M; Stevanovic M; Wörmann SM; Wartmann T; Zhao Y; Halangk W; Voronina S; Tepikin A; Schlitter AM; Steiger K; Artati A; Adamski J; Aichler M; Walch A; Jastroch M; Hartleben G; Mantzoros CS; Weichert W; Schmid RM; Herzig S; Krüger A; Sainz B; Lesina M; Algül H
    Gastroenterology; 2019 Jan; 156(1):203-217.e20. PubMed ID: 30296435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibility to autophagy inhibition is enhanced by dual IGF1R and MAPK/ERK inhibition in pancreatic cancer.
    Stalnecker CA; Coleman MF; Bryant KL
    Autophagy; 2022 Jul; 18(7):1737-1739. PubMed ID: 35201948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TGFB1-induced autophagy affects the pattern of pancreatic cancer progression in distinct ways depending on SMAD4 status.
    Liang C; Xu J; Meng Q; Zhang B; Liu J; Hua J; Zhang Y; Shi S; Yu X
    Autophagy; 2020 Mar; 16(3):486-500. PubMed ID: 31177911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nicotine promotes initiation and progression of KRAS-induced pancreatic cancer via Gata6-dependent dedifferentiation of acinar cells in mice.
    Hermann PC; Sancho P; Cañamero M; Martinelli P; Madriles F; Michl P; Gress T; de Pascual R; Gandia L; Guerra C; Barbacid M; Wagner M; Vieira CR; Aicher A; Real FX; Sainz B; Heeschen C
    Gastroenterology; 2014 Nov; 147(5):1119-33.e4. PubMed ID: 25127677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockage of SLC31A1-dependent copper absorption increases pancreatic cancer cell autophagy to resist cell death.
    Yu Z; Zhou R; Zhao Y; Pan Y; Liang H; Zhang JS; Tai S; Jin L; Teng CB
    Cell Prolif; 2019 Mar; 52(2):e12568. PubMed ID: 30706544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.